Expression of the Three Human Major Histocompatibility Complex Class II Isotypes Exhibits a Differential Dependence on the Transcription Factor RFXAP

ABSTRACT Major histocompatibility complex class II (MHCII) molecules play a pivotal role in the immune system because they direct the development and activation of CD4+ T cells. There are three human MHCII isotypes, HLA-DR, HLA-DQ, and HLA-DP. Key transcription factors controlling MHCII genes have been identified by virtue of the fact that they are mutated in a hereditary immunodeficiency resulting from a lack of MHCII expression. RFXAP—one of the factors affected in this disease—is a subunit of RFX, a DNA-binding complex that recognizes the X box present in all MHCII promoters. To facilitate identification of conserved regions in RFXAP, we isolated the mouse gene. We then delimited conserved domains required to restore endogenous MHCII expression in cell lines lacking a functionalRFXAP gene. Surprisingly, we found that 80% of RFXAP is dispensable for the reactivation of DR expression. Only a short C-terminal segment of the protein is essential for this isotype. In contrast, optimal expression of DQ and DP requires a larger C-terminal segment. These results define an RFXAP domain with an MHCII isotype-specific function. Expression of the three MHCII isotypes exhibits a differential requirement for this domain. We show that this is due to a differential dependence on this domain for promoter occupation and recruitment of the coactivator CIITA in vivo.

[1]  W. Reith,et al.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X , 1988, Cell.

[2]  G. Li,et al.  CCAAT box binding protein NF‐Y facilitates in vivo recruitment of upstream DNA binding transcription factors. , 1994, The EMBO journal.

[3]  B. Peterlin,et al.  Mutations in the Bare Lymphocyte Syndrome Define Critical Steps in the Assembly of the Regulatory Factor X Complex , 2000, Molecular and Cellular Biology.

[4]  W. Reith,et al.  Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression , 2000, Immunological reviews.

[5]  J. Ting,et al.  Transcriptional Scaffold: CIITA Interacts with NF-Y, RFX, and CREB To Cause Stereospecific Regulation of the Class II Major Histocompatibility Complex Promoter , 2000, Molecular and Cellular Biology.

[6]  W. Reith,et al.  Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. , 1997, The New England journal of medicine.

[7]  W. Reith,et al.  CIITA Leucine-Rich Repeats Control Nuclear Localization, In Vivo Recruitment to the Major Histocompatibility Complex (MHC) Class II Enhanceosome, and MHC Class II Gene Transactivation , 2000, Molecular and Cellular Biology.

[8]  W. Reith,et al.  Dissection of functional NF-Y-RFX cooperative interactions on the MHC class II Ea promoter. , 2000, Journal of molecular biology.

[9]  P. Gladstone,et al.  Stable variants affecting B cell alloantigens in human lymphoid cells , 1978, Nature.

[10]  B. Durand,et al.  Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Reith,et al.  Genetic and molecular definition of complementation group D in MHC class II deficiency. , 1998, Human molecular genetics.

[12]  B. Mach,et al.  Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome) , 1993, Cell.

[13]  C. Janeway,et al.  MHC and T cell development. , 1999, Reviews in immunogenetics.

[14]  R. Tjian,et al.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. , 1989, Science.

[15]  C. Xiao,et al.  Nuclear targeting signal recognition: a key control point in nuclear transport? , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[16]  W. Reith,et al.  A Functionally Essential Domain of RFX5 Mediates Activation of Major Histocompatibility Complex Class II Promoters by Promoting Cooperative Binding between RFX and NF-Y , 2000, Molecular and Cellular Biology.

[17]  P. Emery,et al.  Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome. , 1995, Journal of immunology.

[18]  M. Wilkinson.  A rapid and convenient method for isolation of nuclear, cytoplasmic and total cellular RNA. , 1988, Nucleic acids research.

[19]  M. Kozak.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes , 1986, Cell.

[20]  B. Durand,et al.  A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). , 1995, Genes & development.

[21]  M. Fellous,et al.  Differential expression of MHC class II isotype chains. , 1999, Microbes and infection.

[22]  R. Laskey,et al.  Two interdependent basic domains in nucleoplasmin nuclear targeting sequence: Identification of a class of bipartite nuclear targeting sequence , 1991, Cell.

[23]  J. M. Boss,et al.  Regulatory factor X, a bare lymphocyte syndrome transcription factor, is a multimeric phosphoprotein complex. , 1997, Journal of immunology.

[24]  C. Ucla,et al.  RFX1, a transactivator of hepatitis B virus enhancer I, belongs to a novel family of homodimeric and heterodimeric DNA-binding proteins , 1994, Molecular and cellular biology.

[25]  R. Aebersold,et al.  A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients , 1998, Nature Genetics.

[26]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.

[27]  C. S. Moreno,et al.  Formation of a regulatory factor X/X2 box-binding protein/nuclear factor-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. , 1997, Journal of immunology.

[28]  C. Ucla,et al.  Efficient repression of endogenous major histocompatibility complex class II expression through dominant negative CIITA mutants isolated by a functional selection strategy , 1997, Molecular and cellular biology.

[29]  W. D. Cress,et al.  Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region , 2000, Oncogene.

[30]  J. Boss.  Regulation of transcription of MHC class II genes. , 1997, Current opinion in immunology.

[31]  P. J. van den Elsen,et al.  Shared regulatory elements in the promoters of MHC class I and class II genes. , 1998, Immunology today.

[32]  J. Boss,et al.  Associations and Interactions between Bare Lymphocyte Syndrome Factors , 2000, Molecular and Cellular Biology.

[33]  D. Kolakofsky,et al.  Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA. , 1988, The EMBO journal.

[34]  P. Emery,et al.  Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. , 1994, The Journal of biological chemistry.

[35]  P. Chambon,et al.  The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer , 1988, Cell.

[36]  J. M. Boss,et al.  RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. , 1999, Immunity.

[37]  W. Reith,et al.  The bare lymphocyte syndrome and the regulation of MHC expression. , 2001, Annual review of immunology.

[38]  F. Levine,et al.  Revertants from the HLA class II regulatory mutant 6.1.6: implications for the regulation of Ia gene expression. , 1984, Journal of immunology.

[39]  W. Reith,et al.  Regulation of MHC class II genes: lessons from a disease. , 1996, Annual review of immunology.

[40]  W. Reith,et al.  CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. , 2000, Genes & development.

[41]  J. Trowsdale,et al.  Genomic structure and function in the MHC. , 1993, Trends in genetics : TIG.

[42]  P. Emery,et al.  RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency , 1997, The EMBO journal.

[43]  H. Mcdevitt,et al.  Analysis of HLA-D region-associated molecules with monoclonal antibody. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Gönczy,et al.  Inherited immunodeficiency with a defect in a major histocompatibility complex class II promoter-binding protein differs in the chromatin structure of the HLA-DRA gene , 1989, Molecular and cellular biology.

[45]  J. Ting,et al.  Regulation of MHC gene expression. , 1993, Current opinion in immunology.

[46]  W. Reith,et al.  MHC class II regulatory factor RFX has a novel DNA-binding domain and a functionally independent dimerization domain. , 1990, Genes & development.

[47]  P. Sharp,et al.  A high-efficiency HeLa cell nuclear transcription extract. , 1988, DNA.

[48]  S. Westerheide,et al.  Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer. , 1999, Nucleic acids research.

[49]  W. Reith,et al.  Molecular genetics of the Bare lymphocyte syndrome. , 2000, Reviews in immunogenetics.